AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2014

Jun 24, 2014

35124_dirs_2014-06-24_99dfdfb9-17b0-4e51-a78a-b877e787c0db.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2014-06-20

Reporting Person: Tardugno Michael H (CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-20	Celsion Corporation	A	12000	$3.50	Acquired	74521	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-20	Option to Purchase Celsion Corporation Common Stock	$3.50	A	150000	Acquired	2024-06-20	Celsion Corporation Common Stock (150000)	Direct

Footnotes

F1: Represents the per share fair value of the common stock grant based on the closing price of Celsion Corporation Common Stock on the date of grant.

F2: Represents the closing price of Celsion Corporation Common Stock on the date of grant.

F3: The option vests in thirds on June 20, 2014, June 20, 2015 and June 20, 2016.